Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
Clinical trial NCT06083883 · RECRUITING
Trial details
- NCT number
- NCT06083883
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-27
- Primary completion
- 2026-11-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.